Celgene Corporation (CELG)’s Abraxane: A Therapy for Advanced Pancreatic Cancer?
Celgene Corporation (NASDAQ:CELG)’s Abraxane is primarily used to treat breast and lung cancer.
Posts Tagged ‘Celgene Corp (CELG)’
Celgene Corporation (CELG) Soars in 2013; What Does the Future Hold?
The biotechnology industry is one of the favorite industries for investing in up-and-coming companies.
Threshold Pharmaceuticals, Inc. (THLD), Celgene Corporation (CELG)- Tackling Cancer: Pancreatic Cancer’s Biggest Current & Upcoming Players
As I noted 12 weeks ago, cancer statistics are both staggering and disappointing.
Revlimid Gains, Celgene Corporation (CELG) Loses
Celgene Corporation (NASDAQ:CELG) announced good news today about its blockbuster drug Revlimid. Did the stock jump as a result? Nope. Shares actually fell by more than 4%.
Celgene Corporation (CELG) at ASCO: Ho-Hum, Ho-Hum, and Hmmm
Celgene Corporation (NASDAQ:CELG) was one of several companies presenting at the American Society of Clinical Oncology, or ASCO, annual meeting in Chicago this week.
Merck & Co., Inc. (MRK), Celgene Corporation (CELG): 3 FDA Stories You Missed Last Week
Editor's Note: The initial article refers to Abraxane's prostate cancer trials. That is incorrect, Abraxane has priority review for pancreatic cancer.
Merck & Co., Inc. (MRK), GlaxoSmithKline plc (ADR) (GSK): Three FDA Stories You Missed Last Week
The Food and Drug Administration stays busy with approvals, recommendations, and reviews.
ImmunoGen, Inc. (IMGN), AEterna Zentaris Inc. (USA) (AEZS) – Tackling Cancer: Your Best Investing Ideas
Over the past three months, we've taken a deep dive into the 12 cancer types most likely to be diagnosed in the U.S.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Where to Invest for More Health-Care Exposure
You have plenty of choices of where to invest your portfolio.
Celgene Corporation (CELG), Alexion Pharmaceuticals, Inc. (ALXN): Is It Time To Invest In Mid & Small Cap Pharmaceuticals?
Having heard about and invested enough in large-cap pharma, I believe it is time to consider funding smaller firms in the sector.
Novartis AG (ADR) (NVS), Alexion Pharmaceuticals, Inc. (ALXN), Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): 4 Companies Riding the Orphan Drug Rocket
A recent report by EvaluatePharma claims that sales of orphan drugs -- ones that target rare diseases -- will grow at twice the rate of the overall prescription market.
Abbott Laboratories (ABT), Celgene Corporation (CELG) & Three Pharma Companies to Buy in 2013
Currently, a majority of pharma companies are facing the issue of generic competition.
Amgen, Inc. (AMGN): The Ultimate Biotech Diversification Strategy
You want to invest in biotech. You hear about all the monstrous pops and mini-fortunes that are built overnight.
Amgen, Inc. (AMGN) Stock Checkup for May
I have jokingly referred to Amgen, Inc. (NASDAQ:AMGN) in the past as a "senior citizen" of biotech. The company was founded 33 years ago, making Amgen, Inc.
Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Celgene Corporation (CELG): Who’s The Best?
Investors emphasize the "bio" in biotech a great deal. We look at how much patients' health improved in clinical trials.
NVIDIA Corporation (NVDA), Onyx Pharmaceuticals, Inc. (ONXX): Three Things That Caught My Attention Last Week
As we enter the heart of second-quarter earnings reports, I can't help but point out that the majority we've covered over the past year have been better than expected.
Celgene Corporation (CELG), Biogen Idec Inc. (BIIB), Gilead Sciences, Inc. (GILD): Don’t Try to Pick the Best Biotech Company
Rising biotech stars Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), and Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Amgen, Inc. (AMGN): Can Earnings Keep It Soaring?
On Tuesday, Amgen, Inc. (NASDAQ:AMGN) will release its latest quarterly results.
Eli Lilly & Co. (LLY), WellPoint, Inc. (WLP) & Five Must-Watch Earnings Reports in the Health-Care Sector This Week
If you haven't noticed, it's earnings season once again! Believe it or not, there are times when earnings reports slow down in frequency, but this is certainly not one of those...
Amgen, Inc. (AMGN): Is It Too Hot to Handle?
Shares of Amgen, Inc. (NASDAQ:AMGN) have returned over 65% in the past year; 109% if dividends are included. The S&P 500 has returned just over 13%.
Amgen, Inc. (AMGN): The One Biotech Stock Buffett Should Buy
The biotechnology sector can be a land of immense spoils and incredible heartbreak.
QUALCOMM, Inc. (QCOM), Amazon.com, Inc. (AMZN) & More: Five Smart IRA Ideas for the Young Investor
With the tax deadline less than two weeks away, thinking about ways to reduce your tax liability and/or eliminate your future taxes by opening or contributing to an Individual...
Micron Technology, Inc. (MU), Celgene Corporation (CELG) & The Best-Performing NASDAQ-100 Stocks in Q1
It was generally a great quarter for U.S.
Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): Is Celgene Corporation (CELG)’s Pipeline a Fit for Your Portfolio?
Few big biotech firms have been as successful recently as Celgene Corporation (NASDAQ:CELG).
Pfizer Inc. (PFE), Johnson & Johnson (JNJ): Is Obamacare a Disaster Waiting to Happen for Big Pharma?
Big pharma loves Obamacare, right? After all, the main lobbying group for big pharma, the Pharmaceutical Researchers and Manufacturers of America, or PhRMA, spent $150 million...
Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Is This the Next Investing Bubble?
With the Nasdaq Biotechnology Index hitting record highs, Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to chat about whether we're in...
Pfizer Inc. (PFE), Celgene Corporation (CELG): Tackling Cancer: Lung Cancer’s Biggest Current and Upcoming Players
As I noted three weeks ago, cancer statistics are both staggering and disappointing.
Merrimack Pharmaceuticals Inc (MACK) May Be Right For Your Portfolio
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) may be the perfect biotech company for your speculative portfolio.
Will Celgene Corporation (CELG) Help You Retire Rich? – Johnson & Johnson (JNJ), AbbVie Inc (ABBV)
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Better Biotech Buy: Biogen Idec Inc. (BIIB) vs. Celgene Corporation (CELG)
Buying big pharma stocks isn't the only way you can invest in today's best-selling drugs without taking a gamble on a small, risky biotech.
CAPScall of the Week: Clovis Oncology Inc (CLVS)
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
Is Bristol-Myers Squibb Co. (BMY) One of the Best Companies in America?
The Motley Fool recently published its list of The 25 Best Companies in America and while Bristol-Myers Squibb Co.
Peregrine Pharmaceuticals (PPHM) Earnings: An Early Look – Celgene Corporation (CELG)
Earnings season is winding down, with most companies already having reported their quarterly results.
3 Humongous Health-Care Stocks This Week: Celgene Corporation (CELG), Celldex Therapeutics, Inc. (CLDX)
The Dow set an all-time high, but it still was up only 2% for the week. If you want returns to really get excited about, look no further than the health-care sector.
Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)’s Fourth Quarter?
Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech that recently launched...
2 Sides of Celgene Corporation (CELG)’s Apremilast Results
Celgene Corporation (NASDAQ:CELG) has good news -- and it has bad news.
Why Investors Should Love Celgene Corporation (CELG)’s Apremilast
Celgene Corporation (NASDAQ:CELG) shareholders didn't have to wait long for good news in 2013. On Jan.
More Upside on this Biotechnology Giant: Celgene Corporation (CELG)
The Food and Drug Administration added Celgene Corporation (NASDAQ:CELG)’s Pomalyst to the list of approved drugs last Friday.
Pomalyst Takes the Stage: Celgene Corporation (CELG), Johnson & Johnson (JNJ), Onyx Pharmaceuticals, Inc. (ONXX)
Its parent has one of the longest and varied histories in the annals of medicine. Its sibling is a star raking in billions of dollars every year.
Celgene Corporation (CELG)’s New Acquisition — of Celgene
Celgene Corporation (NASDAQ:CELG) announced on Wednesday a $600 million deal to buy a stake in a growing biotech with several successful products on the market and a strong pipeline...
Celgene Corporation (CELG)’s Fastest-Growing Drug
What's the fastest growing drug in Celgene Corporation (NASDAQ:CELG)'s portfolio? It isn't Revlimid, Vidaza, or Abraxane.
Celgene Corporation (CELG): My Favorite Big Biotech for 2013
The biggest biopharmaceutical companies blazed trails and lifted portfolios last year.
Amgen, Inc. (AMGN)’s Future Is Brighter Than You Might Think
When you think about a cutting-edge, one-foot-in-the-future biotech company, no one would blame you for skipping over Amgen, Inc. (NASDAQ:AMGN).
Peregrine Pharmaceuticals (PPHM)’s Epic Failure (Maybe)
Clinical trial 101 says if a trial passes all of its primary endpoints it's successful. If it doesn't, it's not.
Develop Your Own Successful Dividend Portfolio: The Procter & Gamble Company (PG), Oceaneering International (OII)
I am well into my 12th year of investing and have a passion for investing in dividend paying companies.
Celgene Corporation (CELG)’s Fading Star
Celgene Corporation (NASDAQ:CELG) has plenty of stars in its product portfolio. Revlimid currently stands as the brightest of the bunch.
Can Johnson & Johnson (JNJ) Hold Its Ground in the Multiple Myeloma Market?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market leading therapeutic...
